NPM1 and acute myeloid leukemia: When the karyotype is normal and FLT3-ITD mutation is not associated or weakly expressed, NPM1 mutation indicates a favorable outcome in AML according to the ELN 2017 prognosis classification even though the co-mutational environment may further influence this prognostic impact (6, 114).